Carole Ho, Chief Medical Officer at Denali Therapeutics Inc. (DNLI), sold 1,459 shares at $28.48 ($42K) on 2023-01-09, disclosed to the SEC on 2023-01-10.
Scheduled sale ($42k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| DNLI | SELL | 2024-08-22 | $1.1M | — | Filing → |
| DNLI | SELL | 2024-08-15 | $107K | — | Filing → |
| DNLI | SELL | 2024-02-15 | $73K | — | Filing → |